Literature DB >> 23064537

Emergence of increased azithromycin resistance during unsuccessful treatment of Neisseria gonorrhoeae infection with azithromycin (Portland, OR, 2011).

Olusegun O Soge1, Doug Harger, Sean Schafer, Kim Toevs, Kathie A Raisler, Kathy Venator, King K Holmes, Robert D Kirkcaldy.   

Abstract

We describe the emergence of an azithromycin-resistant Neisseria gonorrhoeae variant in a man from Portland, Oregon, during sole treatment with 2 g azithromycin. This report highlights the ease with which gonococcal macrolide resistance can emerge, the threat of multidrug resistant N. gonorrhoeae, and the need for adherence to Centers for Disease Control and Prevention treatment guidelines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23064537      PMCID: PMC6746145          DOI: 10.1097/OLQ.0b013e3182685d2b

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  18 in total

1.  Rationale for a Neisseria gonorrhoeae Susceptible-only Interpretive Breakpoint for Azithromycin.

Authors:  Ellen N Kersh; Vanessa Allen; Eric Ransom; Matthew Schmerer; Sancta Cyr; Kim Workowski; Hillard Weinstock; Jean Patel; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2020-02-14       Impact factor: 9.079

2.  The genes that encode the gonococcal transferrin binding proteins, TbpB and TbpA, are differentially regulated by MisR under iron-replete and iron-depleted conditions.

Authors:  Justin L Kandler; Rosuany Vélez Acevedo; Mary Kathryne Dickinson; Devin R Cash; William M Shafer; Cynthia Nau Cornelissen
Journal:  Mol Microbiol       Date:  2016-07-18       Impact factor: 3.501

3.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

4.  Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Authors:  Carolien M Wind; Maarten F Schim van der Loeff; Alje P van Dam; Henry Jc de Vries; Jannie J van der Helm
Journal:  Euro Surveill       Date:  2017-01-05

5.  Single-Arm Open-Label Clinical Trial of Two Grams of Aztreonam for the Treatment of Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; Negusse Ocbamichael; Angela LeClair; Matthew R Golden
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Authors:  Robert D Kirkcaldy; Olusegun Soge; John R Papp; Edward W Hook; Carlos del Rio; Grace Kubin; Hillard S Weinstock
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

7.  Failure of azithromycin 2.0 g in the treatment of gonococcal urethritis caused by high-level resistance in California.

Authors:  Severin O Gose; Olusegun O Soge; James L Beebe; Duylinh Nguyen; Juliet E Stoltey; Heidi M Bauer
Journal:  Sex Transm Dis       Date:  2015-05       Impact factor: 2.830

8.  Increases in Neisseria gonorrhoeae With Reduced Susceptibility to Azithromycin Among Men Who Have Sex With Men in Seattle, King County, Washington, 2012-2016.

Authors:  Lindley A Barbee; Olusegun O Soge; David A Katz; Julia C Dombrowski; King K Holmes; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

Review 9.  Subversion of nutritional immunity by the pathogenic Neisseriae.

Authors:  Cynthia Nau Cornelissen
Journal:  Pathog Dis       Date:  2018-02-01       Impact factor: 3.166

10.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.